Pemgarda, a monoclonal antibody for unknown version of covid receives and EUA

I can’t begin to describe how stupid this is, and any honest doctor can confirm this (if you find and honest doctor, ask them). Just a few years ago, if I told to my colleagues that a “prophylactic” monoclonal antibody will be greenlighted by the FDA based on a theoretical levels of an unvalidated theoretical surrogate marker of immune response (antibody titers), I would have been laughed out of the room. But those days are sadly over.

Monoclonal antibodies are inherently dangerous treatment options that during “normal” (actively profiteering but solidly pre-genocidal) stage of pharmaceutical industry were considered only for really serious, terminal conditions, and typically after other treatment approaches failed. Risks associated with mAbs include:

Posted in

Iron Will

Leave a Comment

You must be logged in to post a comment.